Search Results - "Zukić, Branka"

Refine Results
  1. 1

    Germline Variants in Cancer Predisposition Genes in Pediatric Patients with Central Nervous System Tumors by Jovanović, Aleksa, Tošić, Nataša, Marjanović, Irena, Komazec, Jovana, Zukić, Branka, Nikitović, Marina, Ilić, Rosanda, Grujičić, Danica, Janić, Dragana, Pavlović, Sonja

    “…Central nervous system (CNS) tumors comprise around 20% of childhood malignancies. Germline variants in cancer predisposition genes (CPGs) are found in…”
    Get full text
    Journal Article
  2. 2

    The pharmacogenomics of vincristine-induced peripheral neuropathy in pediatric acute lymphoblastic leukemia patients in Serbia - a single center experience by Ristivojevic, Bojan, Kotur, Nikola, Stankovic, Biljana, Gasic, Vladimir, Lazic, Jelena, Pavlovic, Sonja, Zukic, Branka

    “…Introduction/Objective. Vincristine (VCR) is one of the key drugs in current treatment protocols for pediatric acute lymphoblastic leukemia (ALL). By…”
    Get full text
    Journal Article
  3. 3

    Genetic basis of otosclerosis by Zukic, Branka, Andjelkovic, Marina, Gasic, Vladimir, Grubin, Jasmina, Pavlovic, Sonja, Djeric, Dragoslava

    Published in Srpski arhiv za celokupno lekarstvo (01-09-2020)
    “…Introduction. Otosclerosis is a disorder of the bone labyrinth and stapes resulting in conductive hearing loss. The genetic basis of otosclerosis still remains…”
    Get full text
    Journal Article
  4. 4

    Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations by Stanković, Biljana, Kotur, Nikola, Gašić, Vladimir, Klaassen, Kristel, Ristivojević, Bojan, Stojiljković, Maja, Pavlović, Sonja, Zukić, Branka

    Published in Journal of medical biochemistry (01-01-2020)
    “…Since there are no certified therapeutics to treat COVID-19 patients, drug repurposing became important. With lack of time to test individual pharmacogenomics…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    HLA genotyping in pediatric celiac disease patients by Stanković, Biljana, Radlović, Nedeljko, Leković, Zoran, Ristić, Dragana, Radlović, Vladimir, Nikčević, Gordana, Kotur, Nikola, Vučićević, Ksenija, Kostić, Tatjana, Pavlović, Sonja, Zukic, Branka

    Published in Biomolecules & biomedicine (01-08-2014)
    “…Celiac disease (CD) is a chronic inflammatory disease in the small intestine triggered by gluten uptake that occurs in genetically susceptible individuals…”
    Get full text
    Journal Article
  9. 9

    PERSONALIZATION OF 6-MERCAPTOPURINE THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA by Milošević, Goran, Dokmanović, Lidija, Krstovski, Nada, Lazić, Jelena, Rodić, Predrag, Pavlović, Sonja, Zukić, Branka, Kotur, Nikola, Janić, Dragana

    Published in Archives of disease in childhood (01-01-2016)
    “…IntroductionTreatment of acute lymphoblastic leukemia (ALL) in children has been significantly improved over past few decades. Optimal use of known…”
    Get full text
    Journal Article
  10. 10

    Molecular genetic markers as a basis for personalized medicine by Pavlović Sonja, Zukić Branka, Stojiljković-Petrović Maja

    Published in Journal of medical biochemistry (01-01-2014)
    “…Nowadays, genetics and genomics are fully integrated into medical practice. Personalized medicine, also called genome-based medicine, uses the knowledge of the…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Molecular Genetic Markers as a Basis for Personalized Medicine / MOLEKULARNO-GENETIČKI MARKERI KAO OSNOV ZA PERSONALIZOVANU MEDICINU by Pavlovic, Sonja, Zukic, Branka, Stojiljkovic, Maja Petrovic

    Published in Journal of medical biochemistry (01-01-2014)
    “…Nowadays, genetics and genomics are fully integrated into medical practice. Personalized medicine, also called genome-based medicine, uses the knowledge of the…”
    Get full text
    Journal Article
  14. 14

    Individualized Therapy: Role of Thiopurine S-Methyltransferase Protein and Genetic Variants by Pavlovic, Sonja, Zukic, Branka

    Published in Journal of medical biochemistry (01-07-2010)
    “…Thiopurine S-methyltransferase (TPMT: EC 2.1.1.67) is an enzyme that metabolizes immunosuppressive thiopurine medications, used in the treatment of autoimmune…”
    Get full text
    Journal Article
  15. 15

    The first insight into the genetic structure of the population of modern Serbia by Drljaca, Tamara, Zukic, Branka, Kovacevic, Vladimir, Gemovic, Branislava, Klaassen-Ljubicic, Kristel, Perovic, Vladimir, Lazarevic, Mladen, Pavlovic, Sonja, Veljkovic, Nevena

    Published in Scientific reports (07-07-2021)
    “…The complete understanding of the genomic contribution to complex traits, diseases, and response to treatments, as well as genomic medicine application to the…”
    Get full text
    Journal Article
  16. 16

    Can Pharmacogenetic Variants in TPMT , MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients? by Jelovac, Marina, Kotur, Nikola, Ristivojevic, Bojan, Pavlovic, Djordje, Spasovski, Vesna, Damjanov, Nemanja, Pavlovic, Sonja, Zukic, Branka

    “…Systemic sclerosis (SSc) is a rare connective tissue disorder with highest morbidity and mortality among rheumatologic diseases. Disease progression is highly…”
    Get full text
    Journal Article
  17. 17

    Clinical Application of Thiopurine Pharmacogenomics in Pediatrics by Pavlovic, Sonja, Kotur, Nikola, Stankovic, Biljana, Gasic, Vladimir, Lucafo, Marianna, Decorti, Giuliana, Zukic, Branka

    Published in Current drug metabolism (01-01-2020)
    “…Thiopurine drugs are used for the treatment of pediatric diseases. Inter-individual differences in the metabolism of these drugs greatly influence the risk of…”
    Get more information
    Journal Article
  18. 18

    Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia by Gasic, Vladimir, Karan-Djurasevic, Teodora, Pavlovic, Djordje, Zukic, Branka, Pavlovic, Sonja, Tosic, Natasa

    Published in Life (Basel, Switzerland) (01-11-2022)
    “…Leukemia is a heterogenous group of hematological malignancies categorized in four main types (acute myeloid leukemia (AML), acute lymphoblastic leukemia…”
    Get full text
    Journal Article
  19. 19

    The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity by Curci, Debora, Stankovic, Biljana, Kotur, Nikola, Pugnetti, Letizia, Gasic, Vladimir, Romano, Maurizio, Zukic, Branka, Decorti, Giuliana, Stocco, Gabriele, Lucafò, Marianna, Pavlovic, Sonja

    Published in Frontiers in pharmacology (09-10-2024)
    “…Nuclear factor kappa B (NF-κB) is a key regulator of immune and inflammatory responses. Glucocorticoid drugs (GC) act through the glucocorticoid receptor (GR)…”
    Get full text
    Journal Article
  20. 20

    The role of FasR/FasL system in pathogenesis of myeloprolyferative neoplasms by Spasovski, Vesna, Tosic, Natasa, Kostic, Tatjana, Zukic, Branka, Stojiljkovic, Maja, Colovic, Milica, Pavlovic, Sonja

    Published in Archives of biological sciences (2010)
    “…Myeloproliferative neoplasms (MPN) are hematological malignancies characterized by uncontrolled cell proliferation and impaired apoptosis. The FasR/FasL system…”
    Get full text
    Journal Article